Scholars@Duke
Rebecca Eli Sadun

Rebecca Eli Sadun

Associate Professor of Medicine
Medicine, Rheumatology and Immunology

Scholarly Works - Conferences

A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

Conference Lupus · August 1, 2026 Background/Purpose: Mycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ... Full text Cite

"TRAQ STARS": IMPROVING TRANSITIONS OF CARE FOR ADOLESCENTS WITH DIABETES

Conference HORMONE RESEARCH IN PAEDIATRICS · November 6, 2025 Link to item Cite

Assessing Whole Health Needs in Systemic Lupus Erythematosus

Conference ARTHRITIS & RHEUMATOLOGY · October 2025 Link to item Cite

Predicting Type 1 and Type 2 SLE Activity Using the LupusPRO

Conference ARTHRITIS & RHEUMATOLOGY · October 2025 Link to item Cite

THE ASSOCIATION BETWEEN TRAUMA AND QUALITY OF LIFE IN SLE.

Conference JOURNAL OF RHEUMATOLOGY · May 21, 2025 Link to item Cite

SOCIAL DRIVERS OF HEALTH IN A LARGE ACADEMIC LUPUS CLINIC

Conference JOURNAL OF RHEUMATOLOGY · May 21, 2025 Link to item Cite

SARS-COV-2 MRNA VACCINE IMMUNOGENICITY IN SLE

Conference JOURNAL OF RHEUMATOLOGY · May 21, 2025 Link to item Cite

Anti-Spike Antibodies in SARS-CoV-2-Vaccinated SLE Patients

Conference ARTHRITIS & RHEUMATOLOGY · September 2024 Link to item Cite

The Influence of Trauma on Features of Type 2 SLE

Conference ARTHRITIS & RHEUMATOLOGY · September 2024 Link to item Cite

Longitudinal Changes in Type 1 & Type 2 SLE Activity

Conference ARTHRITIS & RHEUMATOLOGY · October 2023 Link to item Cite

A Mental Health Workshop for Pediatric Rheumatology Fellows

Conference ARTHRITIS & RHEUMATOLOGY · October 2023 Link to item Cite

WHEN JM PATIENTS LOSE THEIR 'J': TRANSITION CHALLENGES IN MYOSITIS CARE

Conference CLINICAL AND EXPERIMENTAL RHEUMATOLOGY · February 2023 Link to item Cite

Association of Hurried Communication and Low Patient Self-Efficacy With Persistent Nonadherence to Lupus Medications.

Conference Arthritis Care Res (Hoboken) · January 2023 OBJECTIVE: Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented racial minorities have disproportionately lower rates of medication adherence and more severe SL ... Full text Link to item Cite

36.4 “How Are You Doing?”: Training Pediatric Specialty Fellows to Incorporate Mental Health Assessment

Conference Journal of the American Academy of Child & Adolescent Psychiatry · October 2022 Full text Cite

Implementability of a SLE Medication Adherence Intervention

Conference ARTHRITIS & RHEUMATOLOGY · September 2022 Link to item Cite

Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018.

Conference J Rheumatol · September 2021 OBJECTIVE: Since 2010, the rheumatology community has developed guidelines and tools to improve healthcare transition. In this study, we aimed to compare current transition practices and beliefs among Childhood Arthritis and Rheumatology Research Alliance ... Full text Link to item Cite

Association of HCQ Blood Levels with Type 1 and 2 SLE Activity

Conference ARTHRITIS & RHEUMATOLOGY · September 2021 Link to item Cite

Patient Perspectives on Two Distinct Patterns of Type 2 SLE Symptoms

Conference ARTHRITIS & RHEUMATOLOGY · September 2021 Link to item Cite

Intervention to Improve SLE Medication Adherence

Conference ARTHRITIS & RHEUMATOLOGY · September 2021 Link to item Cite

COVID-19 Vaccine Hesitancy in Rheumatology Patients

Conference ARTHRITIS & RHEUMATOLOGY · September 2021 Link to item Cite

Racial Differences in Medication Beliefs Among SLE Patients

Conference ARTHRITIS & RHEUMATOLOGY · September 2021 Link to item Cite

Biologic Differences Between Type 1 and 2 Lupus

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

Longitudinal Changes in Manifestations of SLE

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

The PROMIS-29 as a Measure of Type 1 and 2 SLE Activity

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

Racial Disparities in Lupus Medication Adherence

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

Disability Among Subtypes of SLE

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

Pharmacotherapies Targeting Type 2 SLE Symptoms

Conference ARTHRITIS & RHEUMATOLOGY · October 1, 2019 Link to item Cite

Stepping Stones Toward Cancer Immunotherapy

Conference Journal of Immunotherapy · November 2005 Full text Cite